We are professional 4-Methoxycarbonylmethyl-Benzoic Acid Methyl Ester CAS 52787-14-1 manufacture, supplier and export in China. It is a useful intermediates for Pralatrexate. Pralatrexate is an anti-cancer therapy which is the first drug approved as a treatment for patients with relapsed or refractory peripheral T-cell lymphoma, or PTCL-a biologically diverse group of aggressive blood cancers that have a poor prognosis. We offer the 4-Methoxycarbonylmethyl-Benzoic Acid Methyl Ester CAS NO 52787-14-1 is white powder which is excellent purity, high quality and long shelf life. We offer 4-Methoxycarbonylmethyl-Benzoic Acid Methyl Ester 52787-14-1 in proper packaging of diverse quantity to meet assorted requirements of the clients.

Thera. Category: Anti- cancer

Cas No.: 52787-14-1

Synonym: 4-METHOXYCARBONYLMETHYL-BENZOIC ACID METHYL ESTER;methyl 4-(2-methoxy-2-oxoethyl)benzoate;Methyl 4-methoxycarbonylphenylacetate;Benzeneacetic acid, 4-(Methoxycarbonyl)-,Methyl ester;DiMethyl hoMoterephthalate;4-METHOXYCARBONYLMETHYL-BENZOIC ACID MET

Molecular Formula: C11H12O4

Molecular Weight: 208.21

Assay: ≥97.%

Packing: Export worthy packing

Material Safety Data Sheet: Available on request

Usage: Pralatrexate is an anti-cancer therapy which is the first drug approved as a treatment for patients with relapsed or refractory peripheral T-cell lymphoma, or PTCL- a biologically diverse group of aggressive blood cancers that have a poor prognosis.